Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malaria and red cell genetic defects.

R L Nagel1, E F Roth

  • 1Division of Hematology, Albert Einstein College of Medicine, Bronx, NY 10461.

Blood
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of glucose-6-phosphate dehydrogenase deficiency among schoolboys in Kermanshah, Islamic Republic of Iran.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2009
Same author

Beta-globin-gene haplotypes, mitochondrial DNA, the Y-chromosome: their impact on the genetic epidemiology of the major structural hemoglobinopathies.

Cellular and molecular biology (Noisy-le-Grand, France)·2004
Same author

Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia.

Pediatric pathology & molecular medicine·2003
Same author

Thrombosis-associated gene variants in sickle cell anemia.

Thrombosis and haemostasis·2002
Same author

Correction of sickle cell disease in transgenic mouse models by gene therapy.

Science (New York, N.Y.)·2001
Same author

The challenge of painful crisis in sickle cell disease.

JAMA·2001
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
Same journal

ELISA-negative HIT: antibody recognition and relevance.

Blood·2026
Same journal

EBV and immunodeficiency: the odd couple drawn to the brain.

Blood·2026
Same journal

A bone to pick with ferric carboxymaltose.

Blood·2026
Same journal

A step toward streamlining HIT diagnosis.

Blood·2026
See all related articles

Inherited red blood cell (RBC) defects offer insights into malaria resistance and host-parasite interactions. Further research is needed to fully understand these complex mechanisms for potential therapeutic interventions.

Area of Science:

  • Biochemistry and physiology of host-parasite interactions.
  • Erythrocyte genetics and malaria resistance.

Background:

  • Inherited red blood cell (RBC) defects are known to confer resistance to malaria.
  • The in vitro culture system for Plasmodium falciparum has advanced research in this field.
  • RBC defects can impact parasite invasion, growth, and merozoite release.

Purpose of the Study:

  • To review current knowledge on inherited RBC resistance to malaria.
  • To identify gaps in understanding host-parasite interactions.
  • To highlight areas for future therapeutic intervention.

Main Methods:

  • Review of existing literature on RBC defects and malaria.
  • Analysis of host-parasite biochemical and physiological interactions.
  • Discussion of the impact of RBC defects on parasite lifecycle stages.

Related Experiment Videos

Main Results:

  • Significant advances have been made in understanding malaria resistance mechanisms.
  • Knowledge regarding the influence of the erythrocyte cytoskeleton, phospholipids, and other metabolic products on parasite invasion and growth remains incomplete.
  • The role of erythrocyte enzymes beyond Glucose-6-Phosphate Dehydrogenase (G6PD) in malaria resistance requires further investigation.

Conclusions:

  • Further research is essential to fully elucidate the mechanisms of inherited RBC resistance to malaria.
  • Understanding these mechanisms may reveal novel therapeutic targets.
  • Advanced technologies like DNA analysis and recombinant technology will be increasingly important in studying RBC defects and malaria parasite interactions.